Evidence map›Paper›PMID 33155306›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2020

On the Structure of Intermediates in Enyne Gold(I)-Catalyzed Cyclizations: Formation of trans-Fused Bicyclo[5.1.0]octanes as a Case Study.

Imma Escofet, Helena Armengol-Relats, Hanna Bruss, Maria Besora, Antonio M Echavarren

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Imma EscofetInstitute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology (BIST), Av. Països Catalans 16, 43007, Tarragona, Spain.ORCID http://orcid.org/0000-0002-1790-4255
Helena Armengol-RelatsInstitute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology (BIST), Av. Països Catalans 16, 43007, Tarragona, Spain.ORCID http://orcid.org/0000-0002-9474-2560
Hanna BrussInstitute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology (BIST), Av. Països Catalans 16, 43007, Tarragona, Spain.ORCID http://orcid.org/0000-0001-5781-7749
Maria BesoraDepartament de Química Física i Inorgànica, Universitat Rovira i Virgili (URV), C/ Marcel⋅lí Domingo s/n, 43007, Tarragona, Spain.ORCID http://orcid.org/0000-0002-6656-5827
Antonio M EchavarrenInstitute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology (BIST), Av. Països Catalans 16, 43007, Tarragona, Spain.ORCID http://orcid.org/0000-0001-6808-3007
Institut Català d'Investigació Química · ESUniversitat Rovira i Virgili · ES

Funding

H2020 European Research Council Advanced Grant No. 835080Ministerio de Ciencia Tecnología y Telecomunicaciones PID2019-104815GB-I00
6 · The paper itself

Abstract

The nature of cyclopropyl gold(I) carbene-type intermediates has been reexamined as part of a mechanistic study on the formation of cis- or trans-fused bicyclo[5.1.0]octanes in a gold(I)-catalyzed cascade reaction. Benchmark of DFT methods together with QTAIM theory and NBO analysis confirms the formation of distinct intermediates with carbenic or carbocationic structures in the cycloisomerizations of enynes.

Indexed as

cycloisomerizationcyclopropanationDFT calculationsdienynesgold(I) catalysis

Identifiers

PMID33155306
PMCPMC7756441
OpenAlexW3095894032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.